Yanuki
Finance / Mergers & Acquisitions
Kimberly-Clark (NASDAQ: KMB) and Kenvue (NYSE: KVUE) have announced an agreement for Kimberly-Clark to acquire all outstanding shares of Kenvue in a cash and stock transaction. The deal values Kenvue at an enterprise value of approximately...
Finance / Stocks
Kenvue (KVUE), a global consumer health company featuring brands like Aveeno, BAND-AID, and Listerine, faces headwinds as Jefferies and Deutsche Bank reduce their price targets. This adjustment reflects concerns about turnaround timing, lia...
Health / Pharmaceuticals
Kenvue, the manufacturer of Tylenol, is actively opposing a proposal by the U.S. Food and Drug Administration (FDA) to include a warning label on its product. This label would caution about potential links between Tylenol use during pregnan...
Markets / Stock Market
This article summarizes recent market movements, covering key events such as the addition of Robinhood, AppLovin, and Emcor to the S&P 500, Kenvue's stock decline following reports linking prenatal Tylenol use to autism, and Lucid's rebound...
Finance / Stocks
Kenvue Inc. (KVUE) has been the subject of recent attention from analysts and investors alike. This article summarizes key developments, including analyst ratings, congressional trades, dividend announcements, and stock performance.
Business / Executive News
Thibaut Mongon has stepped down as CEO of Kenvue, the consumer health company spun off from Johnson & Johnson in 2023. This leadership change occurs as Kenvue undertakes a strategic review aimed at improving profitability and simplifying it...
